Hybrid Transgenic Mice Reveal In Vivo Specificity of G Protein–Coupled Receptor Kinases in the Heart
Authors:
- 7 January 2000
- journal article
- other
- Published by Wolters Kluwer Health in Circulation Research
- Vol. 86 (1) , 43-50
Abstract
—G protein–coupled receptor kinases (GRKs) phosphorylate activated G protein-coupled receptors, including α1B-adrenergic receptors (ARs), resulting in desensitization. In vivo analysis of GRK substrate selectivity has been limited. Therefore, we generated hybrid transgenic mice with myocardium-targeted overexpression of 1 of 3 GRKs expressed in the heart (GRK2 [commonly known as the β-AR kinase 1], GRK3, or GRK5) with concomitant cardiac expression of a constitutively activated mutant (CAM) or wild-type α1BAR. Transgenic mice with cardiac CAMα1BAR overexpression had enhanced myocardial α1AR signaling and elevated heart-to-body weight ratios with ventricular atrial natriuretic factor expression denoting myocardial hypertrophy. Transgenic mouse hearts overexpressing only GRK2, GRK3, or GRK5 had no hypertrophy. In hybrid transgenic mice, enhanced in vivo signaling through CAMα1BARs, as measured by myocardial diacylglycerol content, was attenuated by concomitant overexpression of GRK3 but not GRK2 or GRK5. CAMα1BAR-induced hypertrophy and ventricular atrial natriuretic factor expression were significantly attenuated with either concurrent GRK3 or GRK5 overexpression. Similar GRK selectivity was seen in hybrid transgenic mice with wild-type α1BAR overexpression concurrently with a GRK. GRK2 overexpression was without effect on any in vivo CAM or wild-type α1BAR cardiac phenotype, which is in contrast to previously reported in vitro findings. Furthermore, endogenous myocardial α1AR mitogen-activated protein kinase signaling in single-GRK transgenic mice also exhibited selectivity, as GRK3 and GRK5 desensitized in vivo α1AR mitogen–activated protein kinase responses that were unaffected by GRK2 overexpression. Thus, these results demonstrate that GRKs differentially interact with α1BARs in vivo such that GRK3 desensitizes all α1BAR signaling, whereas GRK5 has partial effects and, most interestingly, GRK2 has no effect on in vivo α1BAR signaling in the heart.Keywords
This publication has 30 references indexed in Scilit:
- Distribution of α1-Adrenergic Receptor mRNA Species in Rat HeartJournal of Cardiovascular Pharmacology, 1998
- Targeting the Receptor-G q Interface to Inhibit in Vivo Pressure Overload Myocardial HypertrophyScience, 1998
- Nitric oxide, atrial natriuretic peptide, and cyclic GMP inhibit the growth-promoting effects of norepinephrine in cardiac myocytes and fibroblasts.Journal of Clinical Investigation, 1998
- Transgenic Mice with Cardiac Overexpression of α1B-Adrenergic ReceptorsJournal of Biological Chemistry, 1997
- Mechanism of β-Adrenergic Receptor Desensitization in Cardiac Hypertrophy Is Increased β-Adrenergic Receptor KinaseJournal of Biological Chemistry, 1997
- Identification of a Short Sequence Highly Divergent Between β‐Adrenergic‐Receptor Kinases 1 and 2 that Determines the Affinity of Binding to βγ Subunits of Heterotrimeric Guanine‐Nucleotide‐Binding Regulatory ProteinsEuropean Journal of Biochemistry, 1997
- Phosphorylation of the Type 1A Angiotensin II Receptor by G Protein-coupled Receptor Kinases and Protein Kinase CJournal of Biological Chemistry, 1996
- Effect of Different G Protein-coupled Receptor Kinases on Phosphorylation and Desensitization of the α1B-Adrenergic ReceptorJournal of Biological Chemistry, 1996
- Phosphorylation and Desensitization of the Human β1-Adrenergic ReceptorJournal of Biological Chemistry, 1995
- Mitogen-activated protein kinases mediate changes in gene expression, but not cytoskeletal organization associated with cardiac muscle cell hypertrophy.Journal of Cell Biology, 1994